SMTL ID : 3m5n.3 (3 other biounits)

Crystal structure of HCV NS3/4A protease in complex with N-terminal product 4B5A

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x SER- GLU- CYS- THR- THR- PRO- CYS: SECTTPC peptide(Non-covalent)

SER-GLU-CYS-THR-THR-PRO-CYS.1: 13 residues within 4Å: Chain A: H.78, R.144, I.153, L.156, G.158, S.159, A.160, F.175, R.176, A.177, A.178, V.179, S.180 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.177, A:V.179 Hydrogen bonds: A:G.158, A:S.159, A:A.160, A:R.176, A:A.178, A:A.178, A:S.180, A:S.180 Salt bridges: A:H.78, A:R.144

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: Y.77, G.81 2 PLIP interactions: 2 interactions with chain A Water bridges: A:G.81, A:R.83

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 4 residues within 4Å: Chain A: C.118, C.120, C.166, H.170 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:C.118, A:C.120, A:C.166, H2O.4

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Romano, K.P. et al., Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc.Natl.Acad.Sci.USA (2010)

Release Date

2010-11-24

Peptides

NS3/4A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

NS3/4A

Related Entries With Identical Sequence